Works matching IS 11753277 AND DT 2006 AND VI 6 AND IP 5

Results: 10

Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland: The National FINRISK Study.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 349, doi. 10.2165/00129784-200606050-00008

By:

Alemao, Evo;
Yin, Don;
Sintonen, Harri;
Salomaa, Veikko;
Jousilahti, Pekka

Publication type:

Article

Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.

Published in:

2006

By:

Cavasin MA

Publication type:

Journal Article

Spotlight on Ranolazine in Chronic Stable Angina Pectoris1.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 357, doi. 10.2165/00129784-200606050-00009

By:

Siddiqui, M. Asif A.;
Keam, Susan J.

Publication type:

Article

The Effect of Moxonidine on Endothelial Dysfunction in Metabolic Syndrome.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 343, doi. 10.2165/00129784-200606050-00007

By:

Topal, Ergun;
Cikim, Ayse Sertkaya;
Cikim, Kerim;
Temel, Ismail;
Ozdemir, Ramazan

Publication type:

Article

The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study): Rationale and Baseline Characteristics.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 335, doi. 10.2165/00129784-200606050-00006

By:

Smith, Ronald D.;
Yokoyama, Hiroshi;
Averill, David B.;
Cooke, Lori;
Brosnihan, K. Bridget;
Schiffrin, Ernesto L.;
Ferrario, Carlos M.

Publication type:

Article

The ASCOT Trial: Clarifying the Role of ACE Inhibition in the Reduction of Cardiovascular Events in Patients with Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 327, doi. 10.2165/00129784-200606050-00005

By:

Meurin, Philippe

Publication type:

Article

Medical Treatment of Patients with Heart Failure or Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 313, doi. 10.2165/00129784-200606050-00004

By:

Lipinski, Michael J.;
Vetrovec, George W.

Publication type:

Article

Therapeutic Potential of Thymosin-Î²4 and its Derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in Cardiac Healing After Infarction.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 305, doi. 10.2165/00129784-200606050-00003

By:

Cavasin, Maria A.

Publication type:

Article

Thiazolidinediones in Patients with Diabetes Mellitus and Heart Failure: Implications of Emerging Data.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 297, doi. 10.2165/00129784-200606050-00002

By:

Macfarlane, David P.;
Fisher, Miles

Publication type:

Article

Optimizing the Pharmacologic Treatment of Hypertension: BP Control and Target Organ Protection.

Published in:

American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 287, doi. 10.2165/00129784-200606050-00001

By:

Nilsson, Peter M

Publication type:

Article